Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "... lowering our price target to $0.55"

Ouch, Dutton is NOT happy, too...;-))

http://www.duttonassociates.com/research/ptsc/notes/ptsc_note_041008.pdf

The expressed sentiment by Dutton can be shortened in one sentence: "DON'T BUY PTSC!"

Hm, following my own theory of Dutton being Patriot's communications devil's advocate, what could this mean for the price development next weeks and months?

Furthermore it's interesting, that Dutton DID NOT wait until RG's letter with his comment - why???

I hate questions... 

 

Share
New Message
Please login to post a reply